This drug manufacturer has seen three positive revisions and one negative revision over the last 30 days while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Dynavax Technologies. So make sure to keep an eye on this stock going forward to see if this recent move higher can turn into more strength down the road.
Dynavax Technologies currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the same sector include Actelion Ltd. (ALIOF), Heska Corporation (HSKA) and AMAG Pharmaceuticals, Inc. (AMAG). While Actelion and Heska Corporation hold a Zacks Rank #1 (Strong Buy), AMAG Pharmaceuticals carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment